Do You Know

03-05-2023 : 769 Pharmacists work as Medical Representative, of which 39 work as Senior Medical Representative * 02-06-2020 : 216 non Pharmacists work as Medical Representative, and 54 work as Senior Medical Representative * 05-06-2023 : In Lebanon, 88 generic medicinal products are more expensive than their Originators * 31-12-2019 : A medicinal product refused in Europe is marketed in Lebanon * 05-06-2023 : At least 332 medicinal products are available on the Lebanese market and are not available in the country of origin * 05-06-2023 : The price of the most expensive medicine available in Lebanon is 30434557 LL * 05-06-2023 : At least 1309 medicinal products are more expensive in Lebanon than in the countries of origin * 01-01-2019 : Daktavira, a generic of Daklinza, is registered in Lebanon but has no public price * 31-12-2019 : 352 medicinal products have been declared as non-marketed or withdrawn * 09-11-2021 : 64.72% of lebanese pharmacists are female * 31-12-2019 : 486 medicines were submitted to the Ministry of Health for a marketing authorization, and 514 medicines were registered to date * 15-06-2018 : The Minister of Public Health, has decided to suspend the commercialization of AB Slim (Ab Care Medical Herbs), which contains sibutramine, sildenafil and phenolphthalein * 01-06-2020 : Some Non-Marketed medicines are still imported * 01-06-2020 : Ixempra, a medicinal product withdrawn in Europe is imported to lebanon * 01-06-2020 : A vaccine made in India, removed from WHO list of prequalified vaccines, is submitted for registration in Lebanon * 01-06-2020 : Lebanon has 14 CROs, and is ranked as one of the largest countries in the world in clinical studies. According to the WHO, 817 clinical studies are currently conducted in Lebanon. * 05-01-2021 : * 01-10-2023 : Adakveo is now withdrawn from use in the European Union due to lack of therapeutic efficacy *


ATC
ATC Description

ATC

ATC Code ATC Description
L01XC27 L01XC27 Olaratumab
L01XC28 L01XC28 Durvalumab
L01XC29 L01XC29 Bermekimab
L01XC31 L01XC31 Avelumab
L01XC32 L01XC32 Atezolizumab
L01XC33 L01XC33 Cemiplimab
L01XC37 L01XC37 Polatuzumab vedotin
L01XC38 L01XC38 Isatuximab
L01XC41 L01XC41 Trastuzumab deruxtecan
L01XD L01XD Sensitizers used in photodynamic/radiation therapy
L01XD01 L01XD01 Porfimer sodium
L01XD03 L01XD03 Methyl aminolevulinate
L01XD04 L01XD04 Aminolevulinic acid
L01XD05 L01XD05 Temoporfin
L01XD06 L01XD06 Efaproxiral
L01XD07 L01XD07 Padeliporfin
L01XG01 L01XG01 Bortezomib
L01XG02 L01XG02 Carfilzomib
L01XK L01XK Poly (ADP-ribose) polymerase (PARP) inhibitors
L01XK52 L01XK52 Niraparib and Abiraterone
L01XX L01XX Other antineoplastic agents
L01XX01 L01XX01 Amsacrine
L01XX02 L01XX02 Asparaginase
L01XX03 L01XX03 Altretamine
L01XX05 L01XX05 Hydroxycarbamide
L01XX07 L01XX07 lonidamine
L01XX08 L01XX08 Pentostatin
L01XX09 L01XX09 Miltefosine
L01XX10 L01XX10 Masoprocol
L01XX11 L01XX11 Estramustine
Showing 30 of 6884 Records